Paper Details

  1. Home
  2. Paper Details

[Angiotensin converting enzyme inhibitor moexipril in the treatment of arterial hypertension. Possibilities of moexipril in the treatment of postmenopausal women].

Author: FrolovaL I, OstroumovaO D, PaukovS V

English AbstractA summary of a research paper/publication written in English for a wider audience.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.

Overview

This review examines the efficacy and safety of moexipril, an angiotensin-converting enzyme inhibitor, for the treatment of arterial hypertension. The authors discuss the advantages of moexipril, including its 24-hour duration of action, metabolic neutrality, and low rate of side effects.
Paper Details　
Original Abstract of the Article :
Data on efficacy and safety of angiotensin converting enzyme inhibitor moexipril in the treatment of arterial hypertension are reviewed. Such advantages of this preparation as 24-hour duration of action, lack of loss of hypotensive effect during long term administration, metabolic neutrality, and lo...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/17159885

データ提供：米国国立医学図書館（NLM）

Moexipril: A Camel's Perspective on Blood Pressure Management

This research delves into the world of hypertension management, specifically focusing on the effectiveness and safety of the angiotensin-converting enzyme inhibitor (ACEI) moexipril. The study highlights the beneficial qualities of moexipril, including its extended duration of action, consistent hypotensive effect, metabolic neutrality, and low incidence of side effects. Furthermore, it discusses the potential benefits of moexipril for postmenopausal women, emphasizing its positive impact on bone metabolism and its compatibility with hormone replacement therapy. The research concludes that moexipril presents a promising option for managing hypertension, particularly for postmenopausal women.

The Camel's Perspective: A Gentle Approach to Blood Pressure

This research offers a valuable perspective on the management of hypertension, a condition that affects millions worldwide. It demonstrates the benefits of moexipril, an ACEI that offers a gentle yet effective approach to controlling blood pressure. The researchers' focus on postmenopausal women adds another layer of complexity and demonstrates the importance of considering individual needs and circumstances when managing health conditions.

The Camel's Perspective: A Gentle Approach to Blood Pressure

This research reminds us that managing hypertension is a complex journey, requiring a tailored approach. The study's focus on moexipril and its benefits for postmenopausal women highlights the importance of considering individual needs and circumstances when selecting treatment options. It's like the desert itself – a diverse landscape that demands different strategies for survival.

Dr.Camel's Conclusion

This research suggests that moexipril is a safe and effective ACEI for the management of hypertension, particularly for postmenopausal women. Its positive effects on bone metabolism and compatibility with hormone replacement therapy make it a potentially valuable treatment option.
Date :
  1. Date Completed 2007-01-04
  2. Date Revised 2017-03-10
Further Info :

Pubmed ID

17159885

DOI: Digital Object Identifier

17159885

Related Literature

Article Analysis
・Effects of moexipril・Side Effects of moexipril
SNS
PICO Info
in preparation
Languages

Russian

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.